Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion type Assertion NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_head.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion description "[We analyzed mutations in FGFR3, phosphoinositide 3 kinase catalytic alpha polypeptide (PIK3CA), v-akt murine thymoma viral oncogene homolog 1 (AKT1), v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS), v-Ha-ras Harvey rat sarcoma viral oncogene homolog (HRAS), and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) in 88 urothelial cell carcinomas and the immunohistochemical expression of phospho-v-akt murine thymoma viral oncogene homolog (AKT) and mitogen-activated protein kinase 1 and 2 (pERK1/2) in 80 and 77 urothelial cell carcinomas, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_provenance.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion evidence source_evidence_literature NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_provenance.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion SIO_000772 22417847 NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_provenance.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion wasDerivedFrom befree-2016 NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_provenance.
- NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_assertion wasGeneratedBy ECO_0000203 NP967639.RALzq6gX3tO4BCh-LHo3pLKkWLwPG3EaC1LTQPa6TsF4o130_provenance.